Analysis of the pathogenesis of neurodegenerative disorders using animal models with lysosomal lipid storage diseases.
Analysis of the pathogenesis of neurodegenerative disorders using animal models with lysosomal lipid storage diseases.
批准号:
16300141
负责人:
MATSUDA Junichiro
金额:
$9.79万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2004
资助国家:
日本
项目状态:
已结题
起止时间:
2004 至 2005
中文摘要
点击翻译按钮获取中文摘要
英文摘要
GM1-gangliosidosis is a progressive neurodegenerative disease caused by a deficiency of lysosomal beta-galactosidase (beta-Gal) resulting in progressive neural accumulation of GM1 ganglioside and its derivatives. Little is known about the mechanisms of neurodegeneration in this disease. In this study, we generated several transgenic(TG)/knockout (KO) mice including the GM1 synthase TG/beta-Gal KO mice and also we tried to analyze the pathogenesis of the disorder using these animal models. We established 4 lines of GM1 synthase TG mice and then successfully generated 3 lines of GM1 synthase TG/beta-Gal KO mice. Lipid analysis of one line of TG/KO mice revealed that the level of GM1 storage in their brains was almost same as the KO mice, although the ratio of GM1/asial GM1 storage was slightly increased in the TG/KO mice than that of the KO mice. The severity of the symptoms and the average life spans of these 3 lines of TG/KO mice were similar to those of the KO mice. For analysis of the pathogenesis, we used cerebellar granule cells from postnatal day 8 beta-Gal KO mice. These cells showed abnormal distribution of GM1 ganglioside in plasma membrane, which was accompanied by lysosomal GM1 accumulation. Since GM1 locates in lipid rafts and it is known to regulate Trk neurotrophin receptor-mediated signal transduction, we investigated its behavior in the brain of beta-Gal KO mice. By immunoprecipitation assay, the association of GM1 with Trk was proved to be defective and the phosphorylation of Trk A protein was significantly decreased in the cerebral cortex, midbrain and cerebellum of KO mice compared to wild type littermates. Consistent with this, downstream signaling from Trk A, namely Ca++ signaling via PLCgamma was also impaired. The impairment of Trk-related signaling may contribute to the loss of neuronal function and following neurodegeneration in GM1-gangliosidosis mouse brain.
期刊论文(8)
专著(0)
科研奖励(0)
会议论文
A New Molecular Therapy for Genetically Engineered G_<M1>-Gangliosidosis Model Mice.
基因工程 G_<M1>-神经节苷脂沉积症模型小鼠的新分子疗法。
DOI:
--
发表时间:
2006
期刊:
Proceedings of the Japanese Society of Animal Models for Human Diseases 22(in press)
影响因子:
--
作者:
[Miyagishi, M., Sumimoto, H., Miyoshi, H., Kawakami Y., Taira, K., Suzuki O, 鈴木 義之, Suzuki O et al., Suzuki Y et al.]
通讯作者:
Suzuki Y et al.
GM1-ガングリオシドーシスモデルマウスを用いた新しい治療法の開発
使用GM1-神经节苷脂沉积症模型小鼠开发新的治疗方法
DOI:
--
发表时间:
2006
期刊:
日本疾患モデル学会記録 22(印刷中)
影响因子:
--
作者:
[Miyagishi, M., Sumimoto, H., Miyoshi, H., Kawakami Y., Taira, K., Suzuki O, 鈴木 義之]
通讯作者:
鈴木 義之
DOI:
10.1538/expanim.53.103
发表时间:
2004-04-01
期刊:
EXPERIMENTAL ANIMALS
影响因子:
2.4
作者:
[Noguchi, A, Takekawa, N, Suzuki, O]
通讯作者:
Suzuki, O
Studies on the β-galactosidosis using transgenic mice expressing ganglioside-related glycogenes
-
批准号:13680918
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.24万
-
财政年份:2001
-
负责人:MATSUDA Junichiro
-
依托单位:
Studies on the pathogenesis and the treatment of GM1-gangliosidosis mice
-
批准号:10680784
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.05万
-
财政年份:1998
-
负责人:MATSUDA Junichiro
-
依托单位:
海外基金